10 Questions With Chipinvestor.com's Manoj Nadkarni
Investors in semiconductors can be forgiven for feeling testy these days. Though the chip industry has formally begun a recovery, stock prices have swooned in the past few months. The benchmark Philadelphia Stock Exchange Semiconductor Index has lost more than half its value since peaking in March.
While unit sales of chips are on the upswing, stocks have stayed under pressure as leading companies like Intel (INTC) and AMD (AMD) duke it out for market share. Meanwhile, major equipment suppliers like Novellus (NVLS) and Lam Research (LRCX) just forecast a potential drop-off in orders for the quarter under way. But Manoj Nadkarni, engineer and founder of online investment newsletter Chipinvestor.com, cautions investors against getting too tweaked about the parade of nervous earnings revisions issuing from Wall Street. He offers his own take on how to assess chip and equipment stocks, and explains why he thinks tech giant Intel could see some revenue gains in the current quarter. 1. We're technically supposed to be in the beginning of a semiconductor-industry recovery, even if it's slowed down lately. Do recoveries always look this choppy? If we look back at what's happened in the last few months, part of it is purely [bad] news from some semiconductor and/or semiconductor equipment companies that's obviously hurt the stocks. But there has been positive news as well on a micro level. Many individual companies have been able to meet guidance, and one or two have exceeded it. (TSM) and UMC (UMC) and STMicro (STM) will cut capital expenditures, there's been some concern and a lot more speculation. On top of that, superimpose all this negativity about CEOs telling the truth or not, and more and more well-known companies getting under SEC investigation. None of that helps investor confidence. A big part of this volatility is based on expectations, especially on the part of Street analysts, and also to a large degree investors, because they follow what analysts put out. 2) What do you make of analysts' revised expectations lately? We have a different approach to looking at the [semiconductor] equipment industry. Fundamentally, we think that the way the Street analysts analyze companies -- like predicting revenues and earnings a year in advance -- works well for companies like Procter & Gamble (PG), stable companies with stable earnings. But the equipment industry is very cyclical. Applied Materials (AMAT) has been through three or four cycles over the last 10 years, so the cycles are -- in our mind -- normal. The CEOs themselves cannot predict reliably what their revenues and earnings will be say six months or further out. So if they cannot do that, how can somebody else do it? We don't get into predicting beyond three months or six months. 3) Do you think the Street approach contributes to the volatility in share prices? With AMAT or KLAC (KLAC), you have 15 to 20 analysts covering it, coming up with estimates for fiscal year 2003. And invariably they will change up and down. Then what happens is as analysts change estimates, they upgrade or downgrade the companies and then these stocks see volatility. Often we see -- not with every analyst but with some analysts -- that they will be bullish when the numbers are really good, and bearish when they're bad. But this business is going to come back. We are going to see more and more chips produced in this world, with finer geometries. And if manufacturers don't use equipment from AMAT, they don't have a lot of choices. You can pick any big name, AMAT, Varian (VSEA ), and there will be cycles, but through these, companies continue to grow. So you might say, if you have these cycles, why would you want to even invest in these companies? The reason is that their business is a classic example of oligopolies. For deposition, there's Applied Materials and Novellus (NVLS). For automation, there's Asyst (ASYT) and Brooks-PRI Automation (BRKS). So because of that, because demand for products is fairly inelastic, they grow rapidly and make good money during upturns. There may be 10, 15 different chipmakers, and they all have to have implanters from Varian or Axcelis (ACLS).Manoj M. Nadkarni Founder and Editor, Chipinvestor.com |
TheStreet Premium Services For Personal Service: 877-471-2967
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn MoreETF Profits:
Get money-making ideas from the hottest investment vehicle on the planet. Our experts show you how to play various ETF sectors to help pump-up your portfolio. Learn MoreOptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn MoreReal Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn MoreStocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn MoreTo begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
blog comments powered by Disqus
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 12,783.82 | 1,351.95 | 2,900.94 | 19.84 |
Oil *
116.89
|
|
DOWN
106.64 |
UP
1.99 |
DOWN
26.29 |
DOWN
0.63 |
10 Yr
1.98%
SPDR Gold
168.02
|
|
-0.83%
|
+0.15%
|
-0.90%
|
-3.08%
|
Data delayed 20 minutes |

Connect with TheStreet